文档详情

减低预处理剂量异基因造血干细胞移植后的白血病复发.pdf

发布:2015-09-06约3.28万字共7页下载文档
文本预览下载声明
中国组织工程研究与临床康复笫,2誊第8朔2008—02—19出版 Journal Rehabilitativenssue Research ofClinical Engineering February19,2008V01.12,No.8 欠瓦霖基础医学 减低预处理剂量异基因造血干细胞移植后的白血病复发 牛小青,鹿全意,王昭,赵江宁,张鹏 Influenceof cell stem onleukemicrecurrenceafterreduced allogenichematopoietie transplantation intensityconditioning Niu Xiao-qing,LuQuan—yi,WangZhao,ZhaoJiang—ning,ZhangPeng Abstract stem of AIM:Reduced cell of Deoaranent intensityconditioningallogenichematopoietictransplantation(PdC-HSCT).thepre-conditionalregimen whichis lCSSintensive to stemeell to Hematology, comparedmyeloablativeallogenic transplantation.butgreatercomparedtruly ZhongshanHospital, stemeell toovercome andreduce of non—myeloablativeallogenic transplantation.isexpected regimen—relatedtoxicity relapse Xiamen UnivHsi饥 was leukemia.Tllis toevaluatere.cllrreneeofleukemiaandto factorsrelatedto aRerRIC—HSCT. studydesigned ientify relapse Xiamell 361004. withacute Provincc. METHODS:({)Twenty—threepatients myeloblasticleukemia(AML,n--6),acutelymphoblasticleukemia(ALL,胆7)orFujian
显示全部
相似文档